Related Experiment Video
Updated: Aug 6, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and
Paola de Candia1, Muzaffar Akram, Robert Benezra
1Program in Cell Biology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Abstract:
Id (inhibitor of DNA binding) 4 is a member of the Id family of proteins (Id1-Id4), which function as dominant-negative regulators of basic helix-loop-helix transcription factors. Id factors are involved in numerous cell processes, including cell proliferation, differentiation, and tumorigenesis. We assessed the expression of Id4 messenger RNA (mRNA) in invasive mammary carcinoma from 31 patients, as well as in 21 cases of ductal carcinoma in situ, in 9 lymph node metastases, and in the morphologically normal epithelium adjacent to the carcinoma from the same subjects. In addition, we evaluated Id4 mRNA in atypical ductal hyperplasia from 5 other women and in normal breast tissue from yet another 5 women with no history of breast malignancy or atypia. The distribution of Id4 signal was assessed in relation to that of estrogen receptor (ER) in all samples and correlated with the Her-2 status of the carcinomas. Id4 mRNA was present in the normal ER-negative mammary epithelium in all cases; in contrast, the ER-positive cells present in the normal breast were Id4 negative. Id4 mRNA was not detected in atypical ductal hyperplasia, in 22 of the 23 cases of ductal carcinoma in situ, and in 27 of the 31 invasive carcinomas (P = .0008), all of which were ER positive. Conversely, 3 of the 31 invasive carcinomas were Id4 positive and ER negative. Only 1 ER-positive invasive carcinoma showed focal reactivity for Id4. The expression of Id4 in metastatic carcinoma paralleled that of the primary tumor. No correlation was apparent between Id4 and Her-2. Our data show that Id4 is constitutively expressed in the normal human mammary epithelium but is suppressed in ER-positive breast carcinomas and preneoplastic lesions. In contrast, ER-negative carcinomas appear to be Id4 positive. These results support a possible role of Id4 as a tumor suppressor factor in the human breast and suggest that the expression of Id4 in the mammary ductal epithelium may be regulated by estrogen. Further investigations are required to define the functions of Id4 in the human normal breast and in mammary neoplasia.
Insights
Inhibitor of DNA binding 4 (Id4) is normally present in breast tissue but suppressed in estrogen receptor-positive breast cancers. Id4 may act as a tumor suppressor, with its expression potentially regulated by estrogen.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- Inhibitor of DNA binding (Id) proteins regulate cell proliferation, differentiation, and tumorigenesis.
- Id4 is a member of the Id protein family, acting as a dominant-negative regulator of transcription factors.
Purpose of the Study:
- To assess the expression of Id4 mRNA in various breast tissue types, including normal epithelium, preneoplastic lesions, and malignant carcinomas.
- To evaluate the relationship between Id4 expression, estrogen receptor (ER) status, and Her-2 status in breast cancer.
Main Methods:
- Quantitative assessment of Id4 mRNA expression using messenger RNA (mRNA) analysis.
- Analysis of Id4 distribution in relation to Estrogen Receptor (ER) and correlation with Her-2 status.
- Comparison of Id4 expression across normal breast tissue, atypical ductal hyperplasia, ductal carcinoma in situ, invasive carcinoma, and lymph node metastases.
Main Results:
- Id4 mRNA was constitutively expressed in normal ER-negative mammary epithelium but absent in normal ER-positive cells.
- Id4 mRNA was significantly suppressed in ER-positive atypical ductal hyperplasia, ductal carcinoma in situ, and invasive carcinomas (P = .0008).
- Conversely, ER-negative invasive carcinomas showed Id4 positivity, and Id4 expression in metastases mirrored primary tumors.
Conclusions:
- Id4 is suppressed in ER-positive breast carcinomas and preneoplastic lesions, suggesting a tumor suppressor role.
- Id4 expression in the mammary ductal epithelium may be regulated by estrogen.
- Further research is needed to elucidate Id4's function in normal breast tissue and neoplasia.
Related Concept Videos
MicroRNAs
MicroRNAs
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...

